CTT Pharmaceutical CEO Ryan Khouri acquires 10,000 common shares for $590
CTTH•CEO share purchase
CTT Pharmaceutical Holdings’ CEO Ryan Khouri reported buying 10,000 CTTH shares at USD 0.06 each.
Directly held stake rose to 9,365,456 shares following the purchase.




